- Lobbying by Pharmaceutical Research and Manufacturers of America (PhRMA)
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
|J. Michael Hogan Jr.||DepCoS, Ben Nelson; LegDir, Peter Deutsch|
|Gordon Taylor||COS/LD/Coun,John;Leg Asst/Press Secy,Hayes|
|Elena Tompkins||Senior Legislative Officer, Labor Dept|
|Dean Aguillen||Advr, Pelosi; Dir Intgvt Aff, Labor; LA, Sandlin Sr. Advisor/ Director Member Services/ Floor Asst, Rep. Pelosi; Director Intergovt Affairs/ COS Cong. Affairs/ Special Asst, Labor Dept; LA, Rep. Sandlin|
|Moses Mercado||Dep Chief of Staff, Gephardt; Chief of Staff, Green|
|Wayne Berman||Counselor/Asst Secretary of Commerce for Policy|
|Karissa Willhite||Dep. Chief of Staff, Sen. Menendez; Dep. Exec Director/ Policy Director, House Democratic Caucus; Sr. LA, Rep. Menendez|
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate